VI
ALNY icon

Vestcor Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Vestcor Inc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
5,319
+1,786
+51% +$608K 0.05% 356
2025
Q4 		$1.41M Buy
3,533
+1,006
+40% +$445K 0.04% 401
2025
Q3 		$1.15M Sell
2,527
-309
-11% -$126K 0.03% 433
2025
Q2 		$925K Buy
2,836
+375
+15% +$104K 0.03% 518
2025
Q1 		$665K Buy
2,461
+6
+0.2% +$1.54K 0.02% 576
2024
Q4 		$578K Sell
2,455
-3
-0.1% -$789 0.02% 626
2024
Q3 		$676K Buy
2,458
+420
+21% +$109K 0.02% 587
2024
Q2 		$495K Hold
2,038
– – 0.02% 665
2024
Q1 		$305K Sell
2,038
-755
-27% -$126K 0.01% 822
2023
Q4 		$535K Sell
2,793
-26
-0.9% -$4.43K 0.02% 639
2023
Q3 		$499K Sell
2,819
-14
-0.5% -$2.67K 0.02% 626
2023
Q2 		$538K Hold
2,833
– – 0.02% 593
2023
Q1 		$568K Sell
2,833
-12
-0.4% -$2.52K 0.02% 604
2022
Q4 		$676K Hold
2,845
– – 0.02% 580
2022
Q3 		$569K Buy
2,845
+48
+2% +$9.15K 0.02% 637
2022
Q2 		$408K Buy
2,797
+906
+48% +$129K 0.02% 739
2022
Q1 		$309K Buy
1,891
+424
+29% +$64.6K 0.01% 800
2021
Q4 		$249K Sell
1,467
-271
-16% -$50.4K 0.01% 794
2021
Q3 		$328K Sell
1,738
-225
-11% -$42.2K 0.01% 697
2021
Q2 		$333K Buy
+1,963
New +$288K 0.01% 733

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vestcor Inc's ALNY Position: Q1 2026 in Review

Vestcor Inc increased its Alnylam Pharmaceuticals (ALNY) stake by 51% in Q1 2026, buying an estimated $608K and bringing the position to 5,319 shares worth $1.76M. The position accounts for 0.05% of the portfolio, ranked #356.

Vestcor Inc first reported a position in ALNY in Q2 2021 and has held it in 20 quarters since. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Vestcor Inc held 5,319 shares of Alnylam Pharmaceuticals worth $1.76M as of Q1 2026.
  • Vestcor Inc bought 1,786 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $608K.
  • Alnylam Pharmaceuticals made up 0.05% of Vestcor Inc's portfolio in Q1 2026, its #356 holding.
  • Vestcor Inc first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.